Back to Business

AstraZeneca discontinues lung cancer trial of volrustomig

Business August 17, 2026 at 6:42 AM

AstraZeneca discontinues lung cancer trial of volrustomig

Investing.com

Read at Investing.com

More Stories

Exclusive-Shein eyes company valuation of around $25 billion in Hong Kong IPO, sources say

Exclusive-Shein eyes company valuation of around $25 billion in Hong Kong IPO, sources say

🇺🇸 Investing.com 37m ago

London Gas Oil coils near $1,241 before breakout: Live levels

London Gas Oil coils near $1,241 before breakout: Live levels

🇺🇸 Investing.com 38m ago

Silver stalls below $67 resistance as momentum fades: Live levels

Silver stalls below $67 resistance as momentum fades: Live levels

🇺🇸 Investing.com 38m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play